Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Goodwill & Intangibles (2023 - 2025)

Perspective Therapeutics' Goodwill & Intangibles history spans 6 years, with the latest figure at $50.0 million for Q3 2025.

  • For Q3 2025, Goodwill & Intangibles fell 32.49% year-over-year to $50.0 million; the TTM value through Sep 2025 reached $50.0 million, down 32.49%, while the annual FY2024 figure was $50.0 million, 32.49% down from the prior year.
  • Goodwill & Intangibles for Q3 2025 was $50.0 million at Perspective Therapeutics, roughly flat from $50.0 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $77.3 million in Q3 2023 and bottomed at $50.0 million in Q4 2024.
  • The 3-year median for Goodwill & Intangibles is $74.1 million (2023), against an average of $66.2 million.
  • The largest YoY upside for Goodwill & Intangibles was 4.19% in 2024 against a maximum downside of 32.49% in 2024.
  • A 3-year view of Goodwill & Intangibles shows it stood at $74.1 million in 2023, then plummeted by 32.49% to $50.0 million in 2024, then changed by 0.0% to $50.0 million in 2025.
  • Per Business Quant, the three most recent readings for CATX's Goodwill & Intangibles are $50.0 million (Q3 2025), $50.0 million (Q2 2025), and $50.0 million (Q1 2025).